Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Witty

GSK’s Andrew Witty appointed president of EFPIA

January 5, 2010 Research and Development, Sales and Marketing Andrew Witty, EFPIA, GSK, appointment, research and development, sales and marketing

GlaxoSmithKline chief executive Andrew Witty has been appointed president of EFPIA.He previously served as vice-president of the European industry association for two years and takes …
Appointment

Strong growth predicted for pharma contract services

January 5, 2010 Manufacturing and Production, Research and Development contract research, industry, manufacturing and production

The market for contract services in the pharmaceutical sector has been pegged back since the end of 2008, but looks …
News
Roche's new Building 1

Roche plans striking new Basel offices

January 4, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Basel, Roche, construction

Roche has unveiled plans for its new main office building in Basel, Switzerland, that will accommodate more than 1,800 people …
News

Serge Weinberg joins board at Sanofi-Aventis

January 4, 2010 Research and Development, Sales and Marketing Sanofi-Aventis, appointment, research and development, sales and marketing

Serge Weinberg has joined the board of directors at Sanofi-Aventis, replacing Gunter Thielen, who has resigned for personal reasons. The …
Appointment

Cancer Research UK and Merck KGaA to co-develop leukaemia candidate

January 4, 2010 Research and Development Merck Serono, leukaemia, oncology

Cancer Research UK and Cancer Research Technology (CRT), the charity’s development and commercialisation arm, are to undertake a phase I …
News

Celgene

January 1, 2010 Research and Development, Sales and Marketing Abraxane, Celgene, Revlimid, Thalidomide

Founded in 1986, Celgene was created as a spin off from the Celanese Corporation. Two years later, the company received …
Feature

Pharma mergers and acquisitions in 2009

December 22, 2009 Research and Development, Sales and Marketing Abbott, GSK, J&J, JJ, M&A, MA, Novartis, Pfizer, Wyeth, generics, industry, merger, year in review

This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …
Feature

Contract research news in brief

December 22, 2009 Research and Development AAIPharma, Benten BioServices, CRO, Covance, ICON, PharmaVigilant, Phase Forward, SynRG

Our round-up of developments in the contract research sector includes updates from ICON, SynRG, AAIPharma, Covance, Benten BioServices, Phase Forward …
News

Sanofi’s Plavix combination recommended for European approval

December 21, 2009 Research and Development, Sales and Marketing DuoPlavin, Plavix, Sanofi, cabazitaxel, eplivanserin, idrabiotaparinux

Sanofi-Aventis has received the backing of a key European regulatory committee for its cardiology treatment DuoPlavin, which combines its blockbuster …
News

Dr Michael Rosenblatt appointed chief medical officer Merck

December 21, 2009 Research and Development, Sales and Marketing Dr Michael Rosenblatt, Merck & Co, appointment, appointments, research and development, sales and marketing

Merck & Co. appoints Dr Michael Rosenblatt executive VP and chief medical officer. He will be the company’s primary voice …
Appointment
Merck & Co building

Merck buys Avecia to boost biomanufacturing

December 21, 2009 Manufacturing and Production, Research and Development Avecia Biologics, Cobra, Merck & Co, Recipharm

Merck & Co has bolstered its capabilities in biologics production with the acquisition of contract manufacturer Avecia Biologics. The deal …
News

Chiltern Announces Collaboration with Dr Nawab Qizilbash

December 18, 2009 Research and Development

Dr Nawab Qizilbash, MBChB BSc MRCP (UK) MSc Phil (Oxon) is the Director of OXON Epidemiology Ltd. He served as …
News
Press release
BI Centre_03 2

Boehringer’s ovarian cancer drug enters phase III

December 18, 2009 Research and Development, Sales and Marketing Boehringer, Cancer, ovarian

Boehringer Ingelheim has started a new phase III trial for its investigational cancer drug BIBF 1120. The LUME-Ovar-1 programme will …
News

UK supports stem cell research with online toolkit

December 18, 2009 Research and Development ReNeuron, regenerative medicine, stell cell

A new online resource has been launched to help stem cell researchers in the UK plan a regulatory route for …
News
ICON headquarters

ICON investments will come to fruition in 2010

December 16, 2009 Research and Development ICON, Manchester, translational

Irish contract research organisation ICON has provided additional details on its new translational medicine unit in Manchester, UK, first announced …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026